English
Home > Products > Temozolomide advance intermediate

China Temozolomide advance intermediate Factory

Each individual member from our large performance revenue crew values customers' requirements and organization communication for Temozolomide advance intermediate,CAS NO 360-97-4,360-97-4,Dacarbazine intermediate,Dacarbazine advance intermediate, Trust us and you will gain a lot more. You should truly feel totally free to make contact with us for additional data, we assure you of our greatest notice at all times.
Temozolomide advance intermediate, We always insist on the principle of "Quality and service are the life of the product". Till now, our products have been exported to more than 20 countries under our strict quality control and high level service.

Related Products

Hot Products

  • 3-Amino-1-hydroxyadamantane

    3-Amino-1-hydroxyadamantane

    Product Name:3-Amino-1-hydroxyadamantane
    Molecular Formula:C10H17NO
    Molecular Weight:167.25
    CAS Registry Number:702-82-9
  • 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid

    2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid

    Product Name:2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid
    Molecular Formula:C16H11FN2O3
    Molecular Weight:298.27
    CAS Registry Number:763114-26-7
  • Temozolomide

    Temozolomide

    Product Name:Temozolomide
    Molecular Formula:C6H6N6O2
    Molecular Weight;194.15
    CAS Registry Number;85622-93-1
  • Afatinib diMaleate

    Afatinib diMaleate

    Product Name:Afatinib diMaleate
    Molecular Formula:C28H29ClFN5O7
    Molecular Weight;602.02
    CAS Registry Number;850140-73-7
  • Trimethyl borate

    Trimethyl borate

    Product Name:Trimethyl borate
    Molecular Formula:C3H9BO3
    Molecular Weight:103.91
    CAS Registry Number:121-43-7
  • Cenobamate

    Cenobamate

    Product Name:Cenobamate
    Molecular Formula:C10H10ClN5O2
    Molecular Weight;267.67
    CAS Registry Number;913088-80-9
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept